Annual Fund Operating Expenses |
Jun. 26, 2025 |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tema American Reshoring ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.99% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.99% | |||||||||||||
Fee Waiver or Reimbursement | (0.24%) | [1] | ||||||||||||
Net Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Fee Waiver or Reimbursement over Assets, Date of Termination | June 28, 2027 | |||||||||||||
Tema Durable Quality ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.55% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.55% | |||||||||||||
Tema Heart & Health ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.99% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.99% | |||||||||||||
Fee Waiver or Reimbursement | (0.24%) | [2] | ||||||||||||
Net Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Fee Waiver or Reimbursement over Assets, Date of Termination | June 28, 2027 | |||||||||||||
Tema Oncology ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.99% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.99% | |||||||||||||
Fee Waiver or Reimbursement | (0.24%) | [3] | ||||||||||||
Net Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Fee Waiver or Reimbursement over Assets, Date of Termination | June 28, 2027 | |||||||||||||
Tema Electrification ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.75% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Tema S&P 500 Historical Weight ETF Strategy [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.18% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.18% | |||||||||||||
Tema Luxury ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.99% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Acquired Fund Fees and Expenses | 0.01% | [4] | ||||||||||||
Expenses (as a percentage of Assets) | 1.00% | |||||||||||||
Fee Waiver or Reimbursement | (0.25%) | [5] | ||||||||||||
Net Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Fee Waiver or Reimbursement over Assets, Date of Termination | June 28, 2027 | |||||||||||||
Tema Neuroscience and Mental Health ETF [Member] | ||||||||||||||
Prospectus [Line Items] | ||||||||||||||
Management Fees (as a percentage of Assets) | 0.99% | |||||||||||||
Distribution and Service (12b-1) Fees | 0.00% | |||||||||||||
Other Expenses (as a percentage of Assets): | 0.00% | |||||||||||||
Expenses (as a percentage of Assets) | 0.99% | |||||||||||||
Fee Waiver or Reimbursement | (0.24%) | [6] | ||||||||||||
Net Expenses (as a percentage of Assets) | 0.75% | |||||||||||||
Fee Waiver or Reimbursement over Assets, Date of Termination | June 28, 2027 | |||||||||||||
|